C4X Discovery signs licensing deal with Sanofi worth up to $492 million

(Reuters) -Drug developer C4X Discovery said on Monday it has signed an exclusive licensing deal worth up to 414 million euros ($492.12 million) with French drugmaker Sanofi to develop an oral therapy for the treatment of inflammatory diseases. C4X shares surged 30% in early trade following the news. A unit...